Ontology of Cardiovascular Drug Adverse Events
128 terms(s) returned
Term Type: | Record: 1 to 50 of 128 Records | Page: 1 of 3, First Previous Next Last | Show Records Per Page |
- C [Preparations]
- CANDESARTAN
- CANDESARTAN CILEXETIL
- CANDESARTAN CILEXETIL 4MG TAB [VA Product]
- CAPTOPRIL
- CAPTOPRIL 12.5MG TAB [VA Product]
- CHOLESTYRAMINE
- CHOLESTYRAMINE 4GM/5GM PWDR [VA Product]
- CI_ChemClass
- CI_MoA
- CI_PE
- CI_with
- CLONIDINE
- CLONIDINE 0.1MG/24HRS PATCH [VA Product]
- CLONIDINE HCL 0.1MG TAB [VA Product]
- CLONIDINE HCL 100MCG/ML INJ [VA Product]
- CLONIDINE HYDROCHLORIDE
- CS_Federal_Schedule
- CYCLANDELATE
- CYCLANDELATE 200MG CAP [VA Product]
- Calcium Channel Antagonists [MoA]
- Calcium Channel Interactions [MoA]
- Capsule [Dose Form]
- Captopril [Chemical/Ingredient]
- Carbamates [Chemical/Ingredient]
- Carbohydrates [Chemical/Ingredient]
- Carboxylic Acids [Chemical/Ingredient]
- Cardanolides [Chemical/Ingredient]
- Cardenolides [Chemical/Ingredient]
- Cardiac Complexes, Premature [Disease/Finding]
- Cardiac Contractility Alteration [PE]
- Cardiac Glycosides [Chemical/Ingredient]
- Cardiac Output, High [Disease/Finding]
- Cardiac Output, Low [Disease/Finding]
- Cardiac Rate Alteration [PE]
- Cardiac Rhythm Alteration [PE]
- Cardiomegaly [Disease/Finding]
- Cardiomyopathies [Disease/Finding]
- Cardiomyopathy, Dilated [Disease/Finding]
- Cardiomyopathy, Hypertrophic [Disease/Finding]
- Cardiovascular Abnormalities [Disease/Finding]
- Cardiovascular Activity Alteration [PE]
- Cardiovascular Diseases [Disease/Finding]
- Catecholamines [Chemical/Ingredient]
- Cell Membrane Alteration [PE]
- Cellular Activity Alteration [PE]
- Cellular Structure Alteration [PE]
- Cellular or Molecular Interactions [MoA]
- Central Nervous System Diseases [Disease/Finding]
- Cerebral Arterial Vasoconstriction [PE]